Tag Archives: Biotech and Pharmaceuticals

Gilead says remdesivir coronavirus treatment reduces risk of death

Gilead Sciences announced new findings Friday that its antiviral drug remdesivir reduced the risk of death for severely sick coronavirus patients by 62% compared with standard care alone. The company said its analysis also found that remdesivir treatment was associated with “significantly improved clinical recovery.” The findings are being presented at the Virtual …

Read More »